Nurix Therapeutics, Inc. Quarterly Assets, Current in USD from Q4 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Nurix Therapeutics, Inc. quarterly Assets, Current history and growth rate from Q4 2019 to Q1 2025.
  • Nurix Therapeutics, Inc. Assets, Current for the quarter ending February 28, 2025 was $564M, a 125% increase year-over-year.
Assets, Current, Quarterly (USD)
Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 $564M +$313M +125% Feb 28, 2025 10-Q 2025-04-08
Q4 2024 $619M +$324M +110% Nov 30, 2024 10-Q 2025-04-08
Q3 2024 $456M +$188M +70.2% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $450M +$160M +55.2% May 31, 2024 10-Q 2024-07-11
Q1 2024 $251M -$37.4M -13% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $296M -$22.9M -7.21% Nov 30, 2023 10-K 2025-01-28
Q3 2023 $268M -$86.9M -24.5% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $290M -$16.8M -5.47% May 31, 2023 10-Q 2023-07-13
Q1 2023 $288M +$7.85M +2.8% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $318M +$7.33M +2.36% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $355M -$3.57M -1% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $307M -$89.5M -22.6% May 31, 2022 10-Q 2022-07-07
Q1 2022 $280M -$30.3M -9.75% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $311M +$12.7M +4.25% Nov 30, 2021 10-K 2023-02-09
Q3 2021 $358M -$5.64M -1.55% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $396M May 31, 2021 10-Q 2021-07-13
Q1 2021 $311M Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $298M +$259M +658% Nov 30, 2020 10-K 2022-01-28
Q3 2020 $364M Aug 31, 2020 10-Q 2020-10-14
Q4 2019 $39.4M Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.